Past medical history of pneumonitis linked with increased risk of cancer treatment-associated pneumonitis amongst individuals with advanced non-small-cell lung cancer

New research suggests that amongst individuals with advanced non-small-cell lung cancer and past medical history of pneumonitis, incidence of cancer treatment-associated pneumonitis was greater compared with individuals without past pneumonitis medical histories. New research suggests that individuals with advanced non-small-cell lung cancer who have past medical histories of pneumonitis face increased risks of developing recurrent pneumonitis associated with immune checkpoint inhibitor or chemotherapy administration. The data were presented during a virtual plenary session on lung cancer targeted therapy at the American Association for Cancer Research (AACR) Virtual Annual Meeting I (27—28 April 2020). Pneumonitis — inflammation of lung tissue — can be an acutely life-threatening adverse event associated...